[HTML][HTML] From cell spheroids to vascularized cancer organoids: Microfluidic tumor-on-a-chip models for preclinical drug evaluations

Y Wu, Y Zhou, X Qin, Y Liu - Biomicrofluidics, 2021 - pubs.aip.org
Chemotherapy is one of the most effective cancer treatments. Starting from the discovery of
new molecular entities, it usually takes about 10 years and 2 billion US dollars to bring an …

Microvascularized tumor organoids-on-chips: advancing preclinical drug screening with pathophysiological relevance

J Lim, H Ching, JK Yoon, NL Jeon, YT Kim - Nano Convergence, 2021 - Springer
Recent developments of organoids engineering and organ-on-a-chip microfluidic
technologies have enabled the recapitulation of the major functions and architectures of …

Use and application of organ-on-a-chip platforms in cancer research

Y Yu, TT Zhou, L Cao - Journal of Cell Communication and Signaling, 2023 - Springer
Tumors are a major cause of death worldwide, and much effort has been made to develop
appropriate anti-tumor therapies. Existing in vitro and in vivo tumor models cannot reflect the …

A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine

E Steinberg, R Friedman, Y Goldstein… - Communications …, 2023 - nature.com
Optimal clinical outcomes in cancer treatments could be achieved through the development
of reliable, precise ex vivo tumor models that function as drug screening platforms for patient …

Advances in 3D vascularized tumor-on-a-Chip technology

S Jung, H Jo, S Hyung, NL Jeon - Microfluidics and Biosensors in Cancer …, 2022 - Springer
Tumors disrupt the normal homeostasis of human body as they proliferate in abnormal
speed. For constant proliferation, tumors recruit new blood vessels transporting nutrients …

The tumor-on-chip: Recent advances in the development of microfluidic systems to recapitulate the physiology of solid tumors

G Trujillo-de Santiago, BG Flores-Garza… - Materials, 2019 - mdpi.com
The ideal in vitro recreation of the micro-tumor niche—although much needed for a better
understanding of cancer etiology and development of better anticancer therapies—is highly …

Organ-tumor-on-a-chip for chemosensitivity assay: a critical review

N Kashaninejad, MR Nikmaneshi, H Moghadas… - Micromachines, 2016 - mdpi.com
With a mortality rate over 580,000 per year, cancer is still one of the leading causes of death
worldwide. However, the emerging field of microfluidics can potentially shed light on this …

Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids

VS Shirure, Y Bi, MB Curtis, A Lezia… - Lab on a Chip, 2018 - pubs.rsc.org
Most cancer treatment strategies target cell proliferation, angiogenesis, migration, and
intravasation of tumor cells in an attempt to limit tumor growth and metastasis. An in vitro …

On-chip anticancer drug screening–Recent progress in microfluidic platforms to address challenges in chemotherapy

N Dhiman, P Kingshott, H Sumer, CS Sharma… - Biosensors and …, 2019 - Elsevier
There is an increasing need for advanced and inexpensive preclinical models to accelerate
the development of anticancer drugs. While costly animal models fail to predict human …

Technological advances in tumor-on-chip technology: From bench to bedside

S Bērziņa, A Harrison, V Taly, W Xiao - Cancers, 2021 - mdpi.com
Simple Summary Various 3D in vitro tumor models are rapidly advancing cancer research.
Unlike animal models, they can be produced quickly and are amenable to high-throughput …